The Patent Finder

Godavari Biorefineries Limited

9 patents currently held · Updated Nov 18, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Aug 2032
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Dec 20, 2026
    The maintenance fee for Anticancer compounds (US 11,680,078) comes due Dec 20, 2026. Unpaid by Jun 21, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 of the patents on this record was granted since Aug 20, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 9 of 9

PatentTitleStatus Expires Confidence
US 8,957,230Synthesis of cleistanthin A and derivatives thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,670,123Process for preparation of unsaturated ketone
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,919,318Process for preparation of high flash point frothing agent
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,954,630Process for producing cellulose with low impurities from sugarcane bagasse
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,124,653A Biofiller for Rubber Reinforcement
In force
 · High confidence
In forceHigh confidence
US 11,084,843Anticancer compounds
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,680,078Anticancer compounds
In force
 · From the USPTO record
In forceFrom the USPTO record
US 12,459,930Compounds for the inhibition of unregulated cell growth
In force
 · From the USPTO record
In forceFrom the USPTO record
US 12,760,0105-Hydroxy-1,4-Naphthalenedione for Use in the Treatment of Cancer
In force
 · High confidence
In forceHigh confidence

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

2 pending · 6 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited